# Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid Tumors

> **NCT03154294** · PHASE1 · COMPLETED · sponsor: **Avera McKennan Hospital & University Health Center** · enrollment: 19 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** paclitaxel
- **DRUG:** TAK-228
- **DRUG:** TAK-117

## Key facts

- **NCT ID:** NCT03154294
- **Lead sponsor:** Avera McKennan Hospital & University Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-06
- **Primary completion:** 2020-11-20
- **Final completion:** 2022-11-20
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03154294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03154294, "Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03154294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*